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ABSTRACT 
 
Cognitive aging appears inconsistent across cognitive domains, indicating that domains 
may not all decline at the same rate across individuals.  Individual trajectories of cognitive aging 
can vary widely and are affected by numerous lifestyle and health factors. Alcohol use among 
older adults is known to confer both health risks, typically related to excessive use, and 
protective effects, often associated with moderate consumption. Moderate alcohol use has been 
linked with better cognitive functioning as well as a decrease in cardiovascular mortality and 
systemic inflammation, as compared to heavy or abstinent users.  Given that extant research has 
identified C-reactive protein (CRP) as a mediator between the relationship of moderate alcohol 
use and cardiovascular disease mortality, this study examined the potential mediating role of 
CRP between moderate alcohol use and cognitive performance in later life.  Therefore, the 
primary goals of this thesis were to: (1) examine the relationship between moderate alcohol use 
and cognitive aging over time in a demographically representative, longitudinal survey of 
Americans over the age of 65, and (2) examine a potential biological mechanisms by which this 
putative relationship functions.  The sample utilized for this study consisted of the ADAMS 
sample of the Health and Retirement Study (HRS), a longitudinal, cohort-style study on health, 
retirement, and aging conducted by the University of Michigan and supported by the National 
Institute of Aging.  In order to assess the effect of moderate alcohol use as related to the rate of 
change in cognitive performance over time, a series of slope-intercept models were run.  Logistic 
regressions and Kaplan-Meier survival analysis were used to examine predictors of dementia risk 
and time-to-diagnosis.  Results indicated that moderate alcohol use was significantly associated 
with better baseline functioning across cognitive measures (p ≤.05), but had no significant effect 
on rate of change over time.  Next, structural equation models were employed to examine the 
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effect of alcohol use on cognitive performance as mediated by CRP within each domain.  
Ultimately, results from this study did not support the hypothesized models.  Following this, a 
logistic regression and survival analysis were conducted in order to assess the effect of moderate 
alcohol use on dementia diagnosis.  Results of these analyses indicated that moderate users of 
alcohol develop dementia at lower rates, and later in life, than do abstinent older adults.  Lastly, a 
structural equation model was run to evaluate the effect of alcohol use on dementia diagnosis as 
mediated by CRP.  Primary findings did not support the hypothesized model.  Overall, findings 
from this study suggest that moderate alcohol use is associated with better cognitive functioning 
among community-dwelling older adults, and these relative benefits appear to persist throughout 
later life.  Moderate alcohol use may also be related to a slower rate and onset of dementia 
development.  Future research should investigate alternate biological mechanisms relating 
moderate alcohol use and cognitive functioning in later life.   
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CHAPTER 1: INTRODUCTION 
Cognition 
Changes in an individual’s cognitive abilities can be seen across the lifespan.   Broadly, 
cognitive abilities decline between one and two standard deviations between twenty and seventy 
years of age.  Following this, cognitive abilities tend to decline at an average of about half of a 
standard deviation per decade (Anstey & Low, 2004; Salthouse, 2009, 2012).  The extent of age-
associated cognitive decline differs among individuals and can generally be delineated into 
normative, or non-pathological cognitive aging, and pathological cognitive aging (Deary & Der, 
2005; Park, Polk, Mikels, Taylor, & Marshuetz, 2001; Raz et al., 2005).    However, cognitive 
aging appears somewhat inconsistent across cognitive domains and it is vital to understand that 
domains may not all decline at the same rate across individuals (Anstey & Low, 2004; Park et 
al., 2001).  Moreover, individual trajectories of cognitive aging can vary widely and are affected 
by numerous lifestyle and idiographic factors including components such as diet, neurobiological 
changes, genetics, overall general health, cerebrovascular factors such as atherosclerotic disease, 
and biological processes such as inflammation, and other medical factors (Deary et al., 2009).  
Moderate alcohol use has also been linked with better cognitive functioning as well as a decrease 
in cardiovascular mortality and systemic inflammation, as compared to heavy or abstinent 
consumers (Albert, 2003; Imhof et al., 2001; Lang, Wallace, Huppert, & Melzer, 2007).  The 
relationship between moderate alcohol use and C-reactive protein (CRP), a marker of systemic 
inflammation, has also been explored (Albert, 2003; Imhof et al., 2001).  As a result of the rapid 
demographic growth of the population of older adults, it will be imperative to better understand 
how these factors work both independently and in combination.  Identification of accessible 
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protective factors, and elucidation of their mechanisms, will aid in advancing the public health of 
our aging population both in prevention and intervention strategies. 
Although the amount and pattern of decline that is experienced can be highly 
idiosyncratic, there are also some important group level similarities that should be taken into 
account. The average adult’s cognition declines between one and two standard deviations 
between twenty and seventy years of age (Anstey & Low, 2004); however, the rate of change 
over time is variable between cognitive domains.  For example, there are typically greater 
declines in the domains of processing speed, memory, and some facets of executive functioning 
while verbal functioning tends to show smaller differences (Anstey & Low, 2004; Christensen, 
2001; Craik & Bialystok, 2006; Hartshorne & Germine, 2015).  Age-related changes in cognition 
have been broadly related to changes in brain morphology.  As the brain ages, there is a decrease 
in brain size and volume, an increase in ventricular spaces and cerebrospinal fluid, and loss of 
neuronal bodies in the neocortex, hippocampus, and cerebellum (Deary et al., 2009; Raz & 
Rodrigue, 2006).  The brain is one of the most heavily vascularized systems in the body and 
utilizes approximately 20% of the oxygen and calories consumed by the body.  This high rate of 
metabolism is consistent through later life, even when taking broadly varying motoric and mental 
activity into account (Raichle & Gusnard, 2002).  Hence, neural health is closely related to 
vascular health. 
Consistent with this thesis, significant work has identified cerebrovascular disease, as 
well as associated cerebrovascular components, as principle risk factors for cognitive decline in 
late-life.  Cerebrovascular risk factors that have been implicated include diabetes, 
hypercholesterolemia, atherosclerosis, peripheral arterial disease, hypertension, and elevated 
levels of lipids and fasting blood glucose (Deary et al., 2009; Jefferson, 2014; Raz, Rodrigue, 
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Kennedy, & Acker, 2007; Yaffe et al., 2014).  In general, primary health interventions improve 
aging outcomes by reducing factors associated with disease risk such as diabetes, obesity, 
hypertension, diet, and other lifestyle factors that can affect cerebrovascular health (Anstey & 
Low, 2004; Deary et al., 2009; Warsch & Wright, 2010; Yaffe et al., 2014).   
Dementia 
When considering non-pathological and pathological cognitive aging with regard to 
dementias, it is important to note that dementias differ both quantitatively, in terms of degree of 
cognitive change, as well as qualitatively, in the pattern of decline across cognitive domains 
(Deary et al., 2009; Salmon & Bondi, 2009).  While decline can be seen across many of the 
cognitive domains, it is particularly noticeable in episodic memory, semantic knowledge, and 
portions of executive functioning (Salmon & Bondi, 2009).  Outside of cognitive decline, 
behavioral changes as well as decline in performing activities of daily living are also likely to be 
observed (Deary et al., 2009).  The four most predominant types of dementia are Alzheimer’s 
disease, dementia with Lewy bodies, vascular dementia, and frontotemporal dementia. 
The most common form of dementia is Alzheimer’s disease (Salmon & Bondi, 2009).  In 
2005, it was estimated that 24.2 million people worldwide had dementia and that approximately 
70% of these cases were established as AD (Reitz, Brayne, & Mayeux, 2011).  AD usually 
begins in later life (i.e., 60-70 years of age) and is generally distinguished by neuronal atrophy, 
synapse loss, and the buildup of beta-amyloid plaques and neurofibrillary tangles in medial 
temporal lobe limbic structures (Brion, 2006; Salmon & Bondi, 2009).  Plaques and 
neurofibrillary tangles are the two principal traits found in the brain of individuals with AD. 
While the pattern in which AD pathology progresses is not fully known, evidence suggests that 
the earliest changes begin in the medial temporal lobe structures (e.g., hippocampus, entorhinal 
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cortex).  As these structures are involved with episodic memory, deficits in this area are one of 
the first, and most prominent, factors of AD.  This can cause difficulty with tasks involving 
delayed recall and semantic encoding.  As the neuropathology of AD continues, the cortices of 
the temporal, frontal and parietal lobes are affected, which can cause impairment in higher-order 
cognitive abilities.  These impairments usually include deficits in the areas of semantic memory, 
involving loss of general knowledge and impairment in language abilities.  Additionally, 
cognitive domains of executive function, visual spatial ability, and naming are also frequently 
impaired (Lichtenberg, Murman, & Mellow, 2003).  The clinical course of AD is progressive and 
generally worsens over time.  While symptoms can vary from one individual to another, the 
typical progression of AD can include increased memory loss, repeating statements or questions, 
difficulty in recognizing familiar individuals, impulsive behavior, and wandering.  Further, 
individuals in the more severe stages of AD usually have trouble performing activities of daily 
living (ADLs), such as bathing or getting dressed and may also experience weight loss as well as 
an inability to communicate with those around them (Dubois et al., 2007; Rodgers, 2008).   
Dementia with Lewy bodies (DLB) signifies between 10% and 15% of all cases (and 
occurs in roughly 20% of all elderly patients with dementia) (Boot et al., 2013; Donaghy & 
McKeith, 2014; Salmon & Bondi, 2009) and generally occurs when there is cell loss, a buildup 
of Lewy bodies in brain stem nuclei, presence of Lewy bodies throughout the limbic system and 
neocortex, and neuritic plaques neurofibrillary tangles (similar to the manner in which they are 
seen in individuals with AD).  Patients with vascular dementia (VaD) show an aggregate decline 
in cognitive functioning that is thought to be due to vascular disease within the brain; and 
therefore secondary to multiple or strategically placed infarctions, ischemic injury, or 
hemorrhagic lesions (Salmon & Bondi, 2009).  The incidence of VaD is greatly increased for 
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patients with cerebrovascular risk factors and is diagnosed only once evidence of cerebrovascular 
disease has been confirmed histopathologically. Lastly, frontotemporal dementia (FTD) is a 
progressive neurodegenerative syndrome, characterized by changes in personality as well as a 
decline in cognition and language abilities (Grossman, 2002; Salmon & Bondi, 2009; Warren, 
Rohrer, & Rossor, 2013).  Overall, the clinical course of FTD is a gradual progression, with 
deterioration of the ability to function in activities of daily life as well as increasing disabilities in 
the social, cognitive, and neurological domains.  
Further, there is emerging literature that investigates the consideration of mixed 
dementias.  More specifically, recent research has suggested that dementia patients are likely to 
experience a mix of the subtypes detailed above rather than adhering to one strict diagnosis.  As 
previously discussed, vascular risk factors and vascular disease are linked with increased risks of 
VaD and AD.  Therefore, Helzner and colleagues (2009) examined the relationship between 
vascular factors and the course of AD among a multi-ethnic, community-based, sample.  Their 
results indicated that higher levels of pre-diagnosis total cholesterol, LDL-C (low density 
lipoproteins), and diabetes were associated with quicker cognitive decline among those with AD.  
These results provide additional support with regard to the role of vascular risk factors in course 
of AD, reinforcing the view that dementia patients may experience a mix of the subtypes versus 
one distinct diagnosis. Therefore, diagnostic decisions may not always map on cleanly to the 
underlying neuropathology. 
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CHAPTER 2: ALCOHOL CONSUMPTION AND OLDER ADULTS 
Alcohol Use –A Protective and Risk Factor 
Several studies have identified moderate alcohol use as a protective factor among older 
adults, supporting the relationship between moderate alcohol intake and a reduction in all-cause 
mortality and mortality from coronary heart disease and cerebrovascular disease (Cawthon et al., 
2007; Gronaek et al., 1995; Huang, Qiu, Winblad, & Fratiglioni, 2002; Hulse, Lautenschlager, 
Tait, & Almeida, 2005; Marmot & Brunner, 1991).  Further, many studies have also examined 
the relationship between moderate alcohol consumption and cognitive functioning (Heuberger, 
2009; Huang et al., 2002; Moussa et al., 2014; Mukamal et al., 2003).  Huang, Qiu, Winblad, and 
Fratiglioni (2002) explored the association between moderate alcohol use and risk of incident 
dementia and Alzheimer’s disease in the Kungsholmen Project, a longitudinal study of aging and 
dementia conducted in Stockholm, Sweden.  A sample of 402, community-based dementia-free, 
individuals was followed for a six-year period.  Their results indicated that moderate drinking 
(1–21 drinks per week for men, or 1–14 drinks per week for women), was significantly 
associated with a decreased incidence of dementia in general and Alzheimer’s disease in 
particular, when compared to their non-drinking counterparts.  Similarly, Mukamal et al. (2003) 
examined the prospective relationship between alcohol consumption and risk of dementia among 
older adults.  They utilized the Cardiovascular Health Study (CHS) to identify 373 cases with 
incident dementia and 373 control cases that were matched on the criteria of age, clinic 
attendance, and date of death.  Their results indicated that when compared with both abstention 
and heavy use, moderate alcohol consumption was associated with a lower risk of incident 
dementia among older adults. 
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In addition, there have also been several studies that have examined the relationship 
between moderate alcohol use and specific domains of cognitive functioning.  For instance, 
Ganguli, Vander Bilt, Saxton, Shen, and Dodge (2005) examined the association between 
alcohol use and cognitive decline across six cognitive domains in 1,098 participants with a mean 
age of 74.4 years and an average follow-up of 7 years.  Ganguli et al. (2005) found that, in 
general, mild-to-moderate drinking, when compared with abstaining, was associated with lesser 
average decline on the Mini-Mental State Examination (MMSE) and in the domains of 
trailmaking, learning, and naming.  Further, in a large sample of older women (mean age of 74 
years), Stampfer, Kang, Chen, Cherry, and Grodstein (2005) found that up to one drink per day 
decreased the risk of cognitive decline as measured by the Telephone Interview for Cognitive 
Status (TICS) and the MMSE.  Additional research conducted by Ngandu et al. (2007) 
investigated the effects of moderate drinking in midlife with regard to cognitive functioning in 
later life.  Their results indicated that those who abstained during midlife had worse performance 
on measures of memory, psychomotor speed, and executive function in later life.  Similarly, in a 
sample of 6,033 middle-aged participants, Britton, Singh-Manoux, and Marmot (2004) found 
that those who consumed at least one drink per week had better cognitive function than those 
who abstained.  Lastly, Stott et al. (2008) examined a community based sample of 5,804 
individuals, with a mean age of 75 years, and found that low to moderate drinking was associated 
with slower decline across domains of global cognition, speed of information processing, and 
verbal memory.  Although these studies document the link between moderate alcohol use and 
cognitive performance in later life, the use of a standard and reliable neuropsychology battery, 
adherence to the NIAAA guidelines for categorizing moderate drinking, and sufficient follow-up 
time would greatly increase the clinical utility and interpretation of this relationship.   
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Alcohol use among older adults can also be a health risk, most frequently associated with 
excessive use (Ferreira & Weems, 2008).  Excessive alcohol use can lead to impairment in 
several domains, including but not limited to, impaired driving, interpersonal problems, financial 
problems, and health problems (Centers for Disease Control and Prevention, 2014).  Due to age-
related physiological changes, older adults are at unique risk for negative outcomes associated 
with excessive alcohol use (Heuberger, 2009; National Institute on Alcohol Abuse and 
Alcoholism, 1998; Sorocco & Ferrell, 2006).  As individuals age, these changes can adversely 
affect an older adult’s tolerance to alcohol (Heuberger, 2009).  For example, older adults tend to 
experience higher concentrations of blood alcohol volume.  As people age, the amount of water 
in the body decreases and the amount of fat generally increases.  Alcohol is comprised of water-
soluble molecules that distribute throughout the body. When older adults consume alcohol, they 
experience higher concentrations of blood alcohol volume because there is less water space for it 
to distribute into (Durfour, 1999).  In addition, other factors such as existing diagnoses, number 
of comorbid conditions, and increased use of polypharmacy, puts them at greater risk of 
experiencing adverse reactions to alcohol consumption (Heuberger, 2009; Sorocco & Ferrell, 
2006).  Older adults also are more likely to experience age-related falls and cognitive 
dysfunction which makes them more susceptible to the effects of alcohol (Sorocco & Ferrell, 
2006).  Further, excessive alcohol consumption is likely to have a negative impact on cognitive 
function (Hulse et al., 2005).  Results from cross-sectional studies investigating the effect of 
heavy and frequent alcohol consumption on the risk of dementia have consistently found an 
increased risk of dementia (Huang et al., 2002; Luchsinger, Tang, Siddiqui, Shea, & Mayeux, 
2004; Ruitenberg et al., 2002; Thomas & Rockwood, 2001; Truelsen, Thudium, & Gronbaek, 
2002).  For instance, Thomas and Rockwood (2001) conducted a cross-sectional analysis of the 
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Canadian Study of Health and Aging that included 2,764 (of the 10,268 national cohort) older 
adults.  They found cognitive impairment and dementia was more likely to be found in subjects 
with either questionable or definite alcohol abuse than in older adults with no such history.      
While moderate alcohol use among older adults has been associated with health benefits 
(Ferreira & Weems, 2008), there has been some difficulty when identifying the definition of 
“moderate” alcohol use.  Although moderate alcohol use is generally considered in terms of 
quantity and frequency of consumption, levels of blood alcohol concentration (BAC), and 
negative consequences associated with use, this has been particularly difficult to categorize in 
older adults as a result of the physiological changes that accompany the aging process (i.e., 
decreased tolerance; (Heuberger, 2009).  As a result, there are several ways to define moderate 
alcohol use for older adults.  The National Institute on Alcohol Abuse and Alcoholism 
(NIAAA1998) define moderate use as up to two drinks per day for men and one drink per day 
for women.  However, due to the age-related physiological changes, the NIAAA (1998) suggests 
that older adults consume no more than one drink per day, regardless of gender. However, the 
United States Departments of Agriculture and Health and Human Services 2010 Dietary 
Guidelines for Americans defines moderate drinking as no more than two drinks a day for men 
and one drink per day for women, without specific caveats for age (Agriculture. & Services., 
2010).  As the current guidelines present some ambiguity with regard to moderate drinking 
among older adults, results from the current study may provide evidence that would allow for 
more precise recommendations for the elder adult population. 
With respect to effects on health, results of numerous findings suggest a J- or U-shaped 
relationship between alcohol use and health outcomes, indicating that moderate alcohol intake 
may provide benefits with regard to health (Albert, 2003; Imhof et al., 2001; Lang et al., 2007; 
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Marmot & Brunner, 1991). Cardiovascular mortality is one example of this relationship, as 
greater levels of cardiovascular mortality can be found in both heavy drinkers as well as in non-
drinkers when compared to those who drink in a moderate fashion.  The relationship between 
these groups is complex as heavy drinkers have an increased risk of death compared to moderate 
users; but moderate users have a lower mortality rate than abstainers. One of the possible reasons 
that non-drinkers have higher risk than both abstainers and heavy drinkers, is that these groups 
are likely to include individuals with additional health comorbidities and abstainers can contain 
those who no longer drink due to negative health factors (i.e., ‘sick quitters’; (Marmot & 
Brunner, 1991).  Other studies have investigated whether or not the type of alcoholic beverage 
made a difference (i.e., wine, liquor, or beer); however, ultimately, it appears that type of drink 
did not influence the overall outcome of the relationship.  While the mechanism underlying the 
protective effect of moderate alcohol consumption is not well understood, several possible 
mechanisms have been proposed explain the benefit. 
  
 11 
 
 CHAPTER 3: CLINICAL BIOMARKERS   
C-reactive Protein (CRP) 
C-reactive protein (CRP) is a plasma protein, which acts as a clinical biomarker of 
inflammation as its concentration quickly increases in response to tissue damage and 
inflammatory processes (Ansar & Ghosh, 2013).  Therefore, CRP typically circulates in low 
concentrations in healthy individuals (Stewart, Mainous, & Gilbert, 2002).  Due to CRP’s 
sensitivity as a clinical indicator of inflammation, CRP levels are a valuable indicator of clinical 
disease course as well as response to treatment (Du Clos & Mold, 2004).  There are very few 
pathologies, besides liver failure, and drugs that reduce CRP values (Hirschfield & Pepys, 2003).  
As previously stated, moderate alcohol consumption has been consistently linked with a decrease 
in cardiovascular disease mortality as well as its anti-inflammatory properties. Stewart, Mainous, 
and Gilbert (2002) examined the association between alcohol consumption and CRP on systemic 
inflammation and found that nondrinkers had the highest percentage of elevated CRP levels 
(31%) compared to 21% of low to moderate frequency drinkers, and 18% of high frequency 
drinkers; indicating that alcohol consumption is associated with  lower CRP levels.  Albert 
(2003) also found that lower CRP levels were associated with moderate alcohol consumption, 
when compared with abstention.  Further, a study conducted by Volpato et al. (2004) found that 
individuals who drank between 1 and 7 drinks had the lowest levels of CRP when compared with 
those who abstained or consumed more than 7 drinks on a weekly basis.  As heavy alcohol 
consumption contributes to oxidative stress and inflammation, the pro-oxidant effects of alcohol 
may be one mechanism by which increased cardiovascular risk among heavy users functions 
(Averina, Nilssen, Arkhipovsky, Kalinin, & Brox, 2006).  Taken together, the results of these 
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studies provide support for a potential anti-inflammatory mechanism (CRP) through which 
moderate alcohol consumption may operate.   
Apolipoprotein E (ApoE) 
 Another component that may be a factor in the relationship between moderate alcohol use 
and cognitive functioning is apolipoprotein E (ApoE).  ApoE is a polymorphic protein with three 
polymorphic alleles: e2, e3, and e4; and worldwide allelic frequencies of 8.4%, 77.9%, and 
13.7%, respectively (C. Liu, Kanekiyo, Xu, & Bu, 2013).  There are six possible combinations of 
ApoE (e2/e2, e2/e3, e3/e3, e2/e4, e3/e4, and e4/e4), and the isoforms differ from one another by 
a single amino acid.  Further, e3 appears in the majority of individuals and is generally 
associated with normal functioning, while e2 and e4 are less common and seem to be linked with 
variable functional outcomes (Mahley & Huang, 1999).  ApoE is a crucial regulator of plasma 
liquid levels, facilitating lipid transport between tissues or cells and injury repair in the brain (C. 
Liu et al., 2013; Mahley & Huang, 1999).    
 The relationship between ApoE and the development of AD has been well documented in 
the literature.  Research has shown that the ApoE alleles are one chief genetic risk factor of AD 
associated risk.  Moreover, the e3 allele is seen in the majority of individuals and is generally 
correlated with typical functioning (Mahley & Huang, 1999).  Further, it has been documented 
that the presence of the e4 allele is the strongest genetic risk factor for developing AD, whereas 
individuals with the e2 allele have been shown to have a decreased risk of AD development (C. 
Liu et al., 2013; Mahley & Huang, 1999).  The e4 allele has also been associated with an earlier 
age of onset for AD.  Blacker and colleagues (1997) examined the relationship between presence 
of the e4 allele and age of onset of AD.  They analyzed data from 310 families (679 individuals).  
Their results supported the ApoE-4 allele as a risk factor for AD.  Their results also indicated 
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that individuals who carried two copies of e4 had a significantly younger age of onset than those 
who had only one e4 allele or none at all.  Additionally, Naj et al. (2014) analyzed data from 
over 9,000 respondents and found that each additional copy of the ApoE-4 allele reduced AD age 
of onset by 2.45 years. 
Extant literature concerning the relationship between ApoE genotype and age-related 
cognitive decline presents a complex and unclear picture that does not yet appear to be well 
understood.  Lui et al. (2010) reported that, in individuals older than 50 years of age, carriers of 
the ApoE-4 allele demonstrated worse performance on a measure of verbal learning than did 
those who are non-carriers of the ApoE-4 allele.  Knopman, Mosley, Catellier, and Coker (2009) 
found that individuals with an ApoE-4 allele demonstrated decline in areas of verbal learning and 
processing speed.  Moreover, Downer, Zanjani and Fardo (2014) found that, for non-ApoE-4 
carriers, light and moderate consumption was associated with increased performance in learning 
and memory, while ApoE-4 carriers demonstrated greater decline in these areas.  However, in a 
study cited above, Stampfer et al. (2005) conducted additional analyses as stratified by ApoE 
genotype.  Their results did not find an interaction between either alcohol in-take or ApoE 
genotype nor global cognitive score and ApoE genotype. Similarly, Ngandu et al. (2007) also 
included analyses examining ApoE genotype with regard to alcohol use and cognitive functions.  
Their results also did not find any interactions between ApoE genotype, alcohol use, and 
cognitive performance among memory, psychomotor speed, or executive function.  As this area 
of research continues to develop, we will gain a better understanding of the relationship between 
alcohol consumption, ApoE-4, and their combined effect on cognitive functioning. 
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CHAPTER 4: PROPOSED RESEARCH 
The primary goals of this study were to: (1) examine the relationships of moderate 
alcohol use, with both cognitive aging and dementia risk, respectively in a demographically 
representative, longitudinal survey of Americans over the age of 65, and (2) examine one 
potential biological mechanism by which these putative relationships functions.   
Cognitive Domains 
It is hypothesized that (H1) participants who report consuming moderate alcohol (1-14 
drinks per week) will demonstrate better cognitive performance than participants who report 
abstaining from alcohol use.  (H2) Further, it is hypothesized that C-reactive protein will mediate 
the relationship between cognitive performance and moderate alcohol use, as characterized by a 
significant indirect relationship from moderate alcohol use to cognitive performance through 
CRP.  It is also hypothesized (H3) that Apolipoprotein E (ApoE) will moderate the relationship 
between moderate alcohol use and CRP, and that the moderated CRP variable will mediate the 
relationship between moderate alcohol use and dementia risk.  Building on Hypothesis 1, (H4) it 
is hypothesized that moderate alcohol use will relate to a slower rate of change in cognitive 
performance over time. 
Dementia Diagnosis 
It is hypothesized (H5) that moderate alcohol consumption will predict a lower rate of all-
cause dementia at baseline and a slower increase in all-cause dementia over time.  Further, (H6) 
it is hypothesized that C-reactive protein will mediate the relationship between dementia 
diagnosis and moderate alcohol use, as characterized by a significant indirect relationship from 
moderate alcohol use to diagnosis through CRP.  (H7) It is further hypothesized that ApoE-4 
carriage will moderate the relationship between moderate alcohol use and CRP, whereby 
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moderate drinkers who are ApoE-4 negative will have lower CRP than will those moderate 
drinkers who are ApoE-4 positive.   Finally, (H8) it is also hypothesized that the moderated CRP 
variable will mediate the relationship between moderate alcohol use and dementia risk.   
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CHAPTER FIVE: METHODOLOGY 
Participants 
The present utilized data collected through the Health and Retirement Study (HRS) as 
well as the Aging, Demographics, and Memory Study (ADAMS).  The HRS is a longitudinal, 
cohort-style study on health, retirement, and aging conducted by the University of Michigan and 
supported by the National Institute of Aging.  The first wave of data collection began in 1992 
with adults over 50 years of age who were living in the United States.  Data has been and 
continues to be collected biennially.  Data is collected via interviews, surveys, and links to 
personal records.  This methodology provides a wealth of information about each participant, 
including their physical health, mental health, disability status, employment status, and housing 
situation.  Additional information on HRS survey design as well as data collection methods can 
be found in previously published reports (Hauser & Willis, 2004; Heeringa & Conner, 1995; 
Sonnega et al., 2014).    
The ADAMS is a supplement to the HRS.  The primary goal of the ADAMS is to collect 
data that will allow researchers to estimate the prevalence, predictors, and outcomes of 
individuals diagnosed with dementia inside the U. S. elderly population.  This information will 
aid in facilitating the understanding of the natural history of preclinical dementia as well as the 
ways in which dementia alters the health and social functioning of older adults.  Further, data 
collected through the ADAMS allows for investigation of the relationship between the impact of 
dementia and cognitive impairment.  The waves of data that will be utilized are from 2001, 2002, 
2006, and 2008 and have documented data on 856, 252, 315, and 217 participants, respectively 
(Health and Retirement Study, 2013).  Data used in these analyses incorporate both the direct 
data released from the HRS committee, and cleaned HRS data released by the RAND Center for 
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the Study of Aging (RAND HRS).  Longitudinal data is available at 2-year intervals through 
2012.  The average inter-wave attrition rate is around 20%, the vast majority of which reflects 
death or incapacity.   
 For analyses involving the use of biomarker data, the 2006 data will be utilized as 
baseline for this thesis because this is the year in which CRP levels for participants are reported 
and available.    Participants with missing CRP values, at either the 2006 or 2008 wave were 
excluded (n=577).  Of the remaining 279 participants in the sample, participants with CRP 
values above 10µg/mL (n=29) were excluded as CRP values exceeding 10µg/mL indicate the 
possibility of an acute phase response (Ridker, 2003).  This CRP-related exclusion reduced the 
sample, for biomarker analyses, to 250 participants.   
Subsequently, for all analyses, heavy drinkers (i.e., those consuming more than 14 drinks 
per week) were excluded from this study, and alcohol use was dichotomized as abstinent (0 
drinks per week) and moderate (1-14 drinks per week).  This method, supported by past research, 
allowed us to better elucidate the mechanism by which moderate alcohol has a protective effect 
by comparing moderate drinkers to non-drinkers (see Figure 1).  
Measures 
Demographic Variables.  Data on the following demographic variables were collected through 
either telephone or face-to-face interviews with participants.   
Age/Gender/Race.  The HRS includes data on age, identified gender, and race for 
participants at each wave.  Gender will be determined based on participants’ reports.  In the case 
that reported gender differed from wave to wave, these instances were flagged and gender-
specific health questions were examined to determine participant gender.  Race was established 
by initially inquiring with participants as to whether or not they considered themselves to be 
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Hispanic of Latino.  Following this, participants were then asked, which race they considered 
themselves to be (i.e., White, Black or African-American, American Indian, Alaska Native, 
Asian, Native Hawaiian, Pacific Islander, or something else).  If participants selected more than 
one race, they were asked to specify which race they felt they identified with primarily.  If race 
was missing and participants had identified with being Hispanic or Latino, their race was set to 
“White/Caucasian.”  Efforts were made during participant enrollment to oversample minority 
elders.  
Education.  The HRS data set also includes information pertaining to participants’ level 
of education.  Level of education was assessed by asking participants for the highest grade of 
school, or year of college, that they have completed.  Participants who reported 12 or fewer years 
of school were asked about receiving a High School degree.  Participants who reported 13 or 
more years of school were asked if they received a college degree, with the assumption being 
that they had completed high school, either by obtaining a high school diploma or their General 
Education Development (GED) certificate. If participants reported receiving a college degree, 
they were subsequently asked for the highest degree they have earned.  
Alcohol Use.  Alcohol use will be measured by the average number of reported drinks per week.  
In the HRS data set, alcohol use was determined by first asking participants, “Do you ever drink 
any alcoholic beverages, such as beer, wine, or liquor?”  If participants answered “yes” to the 
initial question, they were then asked two follow-up questions in order to assess the frequency 
and intensity of their alcohol consumption.  The first follow-up question requested that 
participants report the number of days per week, on average, that they consume an alcoholic 
beverage within the last three months.  Participants who reported consuming at least one drink 
per week or greater, were then asked how many drinks they typically consume on days when 
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they do drink, with respect to the last three months.  Average number of drinks per week will be 
computed by multiplying the number of drinks per day by the number of drinking days reported 
per week.   
C-Reactive Protein.  C-reactive protein (CRP) was gathered through an enzyme-linked 
immunosorbent assay (ELISA) using a dried blood spot (DBS) (Crimmins et al., 2013).  ELISA 
is a test that utilizes antibodies in order to detect the presence and amount of a protein, typically 
designated by a color change once the antibody binds to the protein.  The minimum CRP level 
required for detection is 0.035mg/L.  CRP data for 2006 was collected using DBS assays, which 
were conducted at the University of Vermont, and small set done at Biosafe.  CRP data for 2008 
was also collected by DBS assays performed at the University of Vermont.  Imprecision was 
measured as the coefficient of variation (i.e., ratio of standard deviation to the mean), and 
signifies the reliability and validity of the measurement method.  The within-assay imprecision is 
8.1%, and between-assay imprecision is 11.0% (Crimmins et al., 2013).   
Apolipoprotein E.  Apolipoprotein E (ApoE) genotype was determined via a buccal tissue 
sample for DNA testing.  This sample was collected by a specially trained nurse during the in-
person evaluation conducted in the participant’s residence (Health and Retirement Study, 
2013).   Buccal sampling through mouth swabs has been shown to be a non-invasive technique 
that also generates high-quality genomic DNA for single nucleotide polymorphism genotyping 
(Yi, Wu, Luo, Zhou, & Wu, 2014).  
Cognitive Variables.  The instruments that comprise the neuropsychological assessment of the 
ADAMS represent several different domains of neurocognitive functioning that are critical in 
detecting and diagnosing cognitive and neurological disorders.  For the purposes of this research 
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project, the utilized domains include (1) fluency, (2) executive function, (3) visuospatial, (4) 
memory, and (5) global cognition.   
Fluency Domain.  The fluency domain is comprised of CERAD Animal Fluency, the 
Controlled Oral Word Association (COWA), and WAIS-III Digit Span.  Animal Fluency 
assesses an individual’s semantic fluency.  For this test, subjects were asked to name as many 
animals as possible in a one-minute timeframe.  The score is derived from the total number of 
animals that are named.  As animal fluency is a part of the CERAD battery, this test also displays 
sound psychometric properties, with a high test-retest reliability (r = 0.80).  Further, while inter-
rater reliability is not available for this specific test, the inter-rater reliabilities for all subtests 
within the CERAD battery fall within the high range (r = 0.92 - 1.0) (Morris et al., 1989; Welsh-
Bohmer & Mohs, 1997).  The COWA test requires retrieval and oral production of spoken words 
beginning with a designated letter (C, F, and L).  This test assesses an individual’s ability to 
spontaneously produce words within a limited timeframe.  Specifically, the examinee is asked to 
say as many words as possible that begin with the particular letter cited in sixty seconds. There 
are three trails administered, each utilizing a different letter (e.g., F, A, and S;  C, F, and L).  
Further, not only has the COWA been indicated as a sensitive gage of brain dysfunction but the 
administration of verbal fluency tasks is also considered to be a crucial factor in the assessment 
of neuropsychological functioning (Ross et al., 2007).  In terms of psychometric properties, the 
COWA has demonstrated high inter-rater reliability (all indices at or above r = .9) and modest 
test–retest reliability coefficients (r = .6) (Ross et al., 2007; Ross, Furr, Carter, & Weinberg, 
2006). The Digit Span task is taken from the Wechsler Adult Intelligence Scales, Third Edition 
(WAIS-III).  This test includes separate tasks of both forward and backward numerical 
repetition.  For both the forward and backward tasks, the examiner reads a series of number 
 21 
 
sequences to the examinee.  The Digits Forward items require the subject to repeat the number 
sequence in the same order as read aloud by the examiner.  For Digits Backward, the subject 
must repeat the number sequence in the reverse order as presented.  The subject received scores 
for Digits Forward, Digits Backward, and a combination of the two.  The WAIS-III has 
documented consistent reliability and validity, such that inter-rater reliability averaged in the 
high .90’s, and has shown high concurrent validity with the WAIS-R and WISC-III.  Digit Span, 
in particular, was shown to have a reliability score of .90 (calculated via Fisher’s z 
transformation) (Silva, 2008).  
Executive Function Domain.  The executive function domain includes the Reitan Trail 
Making Test (TMT), Part B and the Symbol-Digit Modalities Test (SDMT).  The TMT is 
administered in two parts; A and B.  For Part A, the subject is asked to draw lines connecting 
consecutively numbered circles on a worksheet.  Part B asks that the subject connect 
consecutively numbered and lettered circles by alternating between the numbers and letters.  The 
test-retest reliability is moderate to high for Part A (r=.36 to .79) and Part B (r=.44 to .89).  In 
addition, inter-rater reliability has been found to be high for both Part A r=(.94) and Part B 
(r=.90) and content validity has been shown to correlate moderately between Part A and B 
(Reitan, 1958).  The SDMT requires the subject to exchange a number for randomized 
presentations of various geometric symbols.  The subject is provided with a printed key, which 
matches each of the Arabic numbers (1-9) with a specific symbol, so that each number is 
represented by its own unique symbol.  This test can be administered either via a written or oral 
format.  While the preferred method of testing is the written format, subjects who were unable to 
execute this method (e.g., major motor impairment such as hemiparesis, Parkinsonism, etc.) were 
administered the oral version of the test.  However, the written and oral scores are not considered 
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to be equivalent.  With regard to the psychometric properties of the SDMT, the test-retest 
reliability is .80 for the written format and .76 for the oral format.  Further, the SDMT has also 
been shown to be sensitive to various types of neurological disorders (Sheridan et al., 2006). 
Visuospatial Domain.  The visuospatial domain is comprised of the Benton Visual 
Retention Test (BVRT) and the CERAD Constructional Praxis and CERAD Constructional 
Praxis Delayed Recall tasks.  This test required the subject to reproduce designs following a 10-
second exposure. The BVRT includes a total of ten different designs.  The scoring of the BVRT 
is calculated based on the types of errors that are made.  These can include Omissions, 
Distortions, Perseverations, Rotations, Misplacements, Size Errors, Total Left, and Total Right.  
With regard to the psychometric properties of the BVRT, the test has adequate alternate form 
reliability (ranging from .79 to .84 among the three forms).  In addition, inter-rater reliability for 
the BVRT is high, with reliabilities reaching from .90 to .97 for the Number Correct Score and 
from .94 to .98 for the Number Error Score (Benton, 1998).  With regard to the CERAD 
Constructional Praxis and CERAD Constructional Praxis Delayed Recall tasks, the 
constructional praxis task tests the ability of the subject to copy four geometric forms of 
fluctuating difficulty (circle, overlapping rectangles, diamond and cube).  Each figure is printed 
on the top portion of a sheet of paper and subsequently presented to the subject, individually.  
The subject is then asked to copy the figure in the blank space. The delayed recall task was 
administered after the Recognition Trial for the Word List Learning task and requires the subject 
to draw the original four figures from memory.  The scoring range for this test ranges from zero 
to eleven (Fillenbaum, Burchett, Unverzagt, Rexroth, & Welsh-Bohmer, 2011).  The 
constructional praxis task has demonstrated high inter-rater reliability (0.92) and high test-retest 
reliability (0.80) (Morris et al., 1989; Welsh-Bohmer & Mohs, 1997) 
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Memory Domain.  The memory domain includes the CERAD Word List Delayed Recall 
and CERAD Word List Recognition tasks as well as WMS Logical Memory II and the Fuld 
Object Memory Evaluation (FOME).   These tasks contain ten high imagery words that are 
visually presented for two seconds each.  The individual reads each word aloud as it is presented 
and is subsequently tested on an immediate recall procedure.  There are three trials with 
immediate recall and one trial of delayed recall.  These are followed by one trial of a recognition 
task for ten target items, which appear among ten non-target items.  Intrusions on the task are 
noted when a word is stated during recall that was not among the original words on the stimulus 
list.  Lastly, if the subject was visually impaired or unable to read for any other reasons, the word 
list was read to the subject.  In these cases, the individual was asked to repeat the words as they 
were read.  The psychometric properties of the CERAD have been found to be both valid and 
reliable (Morris et al., 1989).  More specifically, the Word List Learning Trials were shown to 
have high inter-rater reliability, with an intra-class correlation of r = 1.0.  In addition, test-retest 
reliability for Word List Learning Trials, Word List Delayed Recall, and Word List Recognition 
have been found to be r = 0.80, r = 0.56, and r = .53, respectively (Morris et al., 1989; Welsh-
Bohmer & Mohs, 1997).  During the Wechsler Memory Scale (WMS) Logical Memory II 
(Delayed Recall) task, two brief stories were read to the subject.  Following this, the subject was 
asked to recall as much of the story as they could.  The delayed recall task asked subjects to 
again recall as much of the stories as possible and was administered following completion of the 
Symbol-Digit Modalities Test.  The psychometric properties for the WMS Logical Memory I and 
II have been well validated.  The four to six week test-retest reliability has been assessed at r = 
0.75 for Logical Memory II.  In addition, the Logical Memory subtest has demonstrated an inter-
rater reliability of 0.99 (Franzen & Iverson, 2000). The FOME is centered around the recall of 
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ten common household objects, which are first identified by touch.  The task utilized the 
modified 3-trial version and each recall trial was preceded by a distractor task which required 
word generation.  Further, the subject was selectively reminded of items they were unable to 
recall.  The FOME has demonstrated sound psychometric properties, with an alternate form 
reliability reported at .71, as well as test-retest reliability (r = .92), and high sensitivity and 
specificity for both total retrieval and delayed retrieval scores (Chung & W, 2009; Wall, 
Deshpande, MacNeill, & Lichtenberg, 1998) 
Global Cognition Domain.  The domain of global cognition was calculated as an 
aggregate of all measures from each domain.   
Statistical Methods 
Cognitive Domains. 
To examine the effect of moderate alcohol use on the rate of change in cognitive 
performance over time, a series of slope-intercept models were run.  For all slope-intercept 
models, control variables included number of years of education, medical burden (total number 
of medical diseases), and marital status.  Following this, principal component analysis was 
conducted to ensure appropriate fit of the cognitive measures within each domain.  All data was 
standardized and measures on which stronger performance yields higher scores (TMT, for 
instance) were inverted (Tabachnick & Fidell, 2013). Once the factor structure for the cognitive 
variables was established, the effect of moderate alcohol use on each domain of cognitive 
performance (memory, executive functioning, fluency, visuospatial, and global cognition) was 
assessed via structural equation modeling.  More specifically, a path analysis utilizing a 
mediation analysis adapted from Baron and Kenny (1986) was used to determine the overall 
relationship between alcohol use, C-reactive protein, and cognitive performance.  Control 
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variables included gender, age, education, race, and medical burden.  Mediation of this 
relationship was identified based on a significant indirect relationship from alcohol to cognitive 
performance through CRP.  As in multiple regression, moderation models using SEM paradigms 
model both the direct effect of a moderating variable, and the cross-product of the moderating 
variable with the variable hypothesized to be moderated. Thus, moderation of the relationship 
between alcohol use and CRP was examined by modeling the direct effect of ApoE carriage and 
the effect of the cross-product of ApoE carriage and moderate drinking on CRP.  In such a 
paradigm, significant moderation is indicated by a significant pathway coefficient for the cross-
product on the outcome variable, in this case, CRP.  Data was prepared in SPSS and slope-
intercept, as well as, structural equation model analyses were performed utilizing the Mplus 
software program (L. K. Muthen & Muthen, 2012). 
Dementia Diagnosis. 
The effect of moderate alcohol use on onset of dementia was determined using a logistic 
regression model.  Both dementia onset and alcohol use were coded as binary variables.  With 
regard to alcohol use, “Moderate Use” represents participants who reported consuming an 
average of 1-14 drinks per week; and “Abstained” represents participants who reported that they 
did not consume any alcoholic beverages during a typical week.  Additional predictor variables 
used in the analysis include gender, age, race, and number of years of education. 
Following this, a Kaplan-Meier survival analysis was performed to assess the effects of 
alcohol use (moderate versus abstaining) on the age of onset of dementia.  The Kaplan-Meier 
method, also known as the product-limit estimate of the survival function, does not utilize a 
specified interval size, but instead calculates survival statistics each time an event is observed 
(Tabachnick & Fidell, 2013).  One of the main characteristics that differentiates the Kaplan-
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Meier survival analysis from other survival analyses is its ability to censor data.  Censoring 
occurs when there is incomplete survival time data for participants (i.e., dementia onset was not 
noted during the span of the data collection; participants attritted from the sample).  As the 
sample for the current study included both participants who either did not receive a diagnosis or 
attritted from the sample, a Kaplan-Meier survival analysis was performed in order to evaluate 
the effect of alcohol use on the age of onset for dementia diagnosis (Collett, 1994; Tabachnick & 
Fidell, 2013).  Survival probabilities for dementia diagnosis among those who abstained from 
alcohol use were compared with survival probabilities for dementia diagnosis among those who 
consumed alcohol moderately.  Group differences were tested via the log-rank test in SPSS. 
Finally, the effect of moderate alcohol use on dementia onset was assessed via structural 
equation modeling.  More specifically, a path analysis utilizing a mediation analysis adapted 
from Baron and Kenny (1986) was used to determine the overall relationship between alcohol 
use, C-reactive protein, and dementia onset.  Control variables included gender, age, education, 
and medical burden.  As the outcome variable for this analysis was categorical (those who 
did/did not receive a dementia diagnosis), it was necessary to code this appropriately in the 
Mplus syntax.  When an outcome variable is categorical in Mplus, the estimator should be 
changed to reflect weighted least squares with mean and variance adjustment (WLSMV) rather 
than the standard maximum-likelihood (ML) estimator.  WLSMV is a robust estimator which 
does not assume normally distributed variables and provides the best option for modeling 
categorical outcomes as it utilizes a diagonal weight matrix with robust standard errors and 
mean- and variance-adjusted χ2 test statistic (Brown, 2006; Hancock, 2006; B. O. Muthen & 
Asparouhov, 2002; Yu, 2002).  Mediation of the hypothesized relationship was identified based 
on a significant indirect relationship from alcohol use to dementia onset through CRP.  Further, 
 27 
 
moderation of the relationship between alcohol use and CRP was identified by a significant 
pathway from moderate alcohol use to CRP through ApoE.  Data was prepared in SPSS and 
structural equation model analyses were performed utilizing the Mplus software program (L. K. 
Muthen & Muthen, 2012).  
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CHAPTER SIX: RESULTS 
Cognitive Domains. 
The full ADAMS sample (Waves A-D) consisted of 856 participants.  As displayed in 
Table 1, the sample was predominantly female (58.6%), largely White/Caucasian (76.9%), and 
had a mean age of 81.56 years (SD=7.17), and a mean education of 10.03 years (SD=4.35).  The 
sample reported a mean medical burden score of 7.08 (SD=3.67).  Approximately 79% of 
participants included in this study reported being abstinent from alcohol.  Table 1 provides 
separate sample characteristics for non-drinkers (n=679) and moderate drinkers (n=139).  As 
expected, moderate drinkers differed significantly on certain variables compared to non-drinkers.   
Specifically, compared to non-drinkers, moderate drinkers were more likely to be 
Caucasian (χ2(1, N=818)=16.01, p<0.001), male(χ2(1, N=818)=28.62, p<0.001), and partnered (χ2(1, 
N=818)=15.07, p<0.001).  In addition, compared to non-drinkers, moderate drinkers were more 
educated (χ2(17, N=818)=74.36, p<0.001) and had less medical burden (χ2(1, N=818)=37.55, p<0.05), 
overall.  However, as certain variables (i.e., biomarker data) were not collected from all 
participants, it should be noted that not all analyses were able to utilize the full sample of 
ADAMS participants.  Therefore, the structural equation models, which employed the use of 
both CRP and ApoE data, were subject to a smaller sample size.  More specifically, of the 856 
ADAMS participants, 250 participants had CRP and ApoE data, collected in either Wave C or 
Wave D.  The available data from these two waves were merged, in order to optimize both 
sample size as well as statistical power.  
 To begin, we examined the hypothesis (H4) that moderate alcohol use would relate to a 
slower rate of change in cognitive performance over time, utilizing slope-intercept models for 
each cognitive measure.  The final sample for the slope-intercept models included the full 
 29 
 
ADAMS sample of 856 participants (demographics for these individuals can be found in Table 
1).  Overall, results of the slope-intercept models produced a similar pattern across cognitive 
domains (Figure 2).  As a broad generalization, moderate alcohol use was significantly 
associated with increased baseline functioning (p ≤.05), but had no significant effect on rate of 
change over time.  More specifically, individuals who engaged in using alcohol in a moderate 
manner displayed better performance at baseline across measures of cognition, but this effect 
was not associated with rate of change in performance over time suggesting that these 
differences at baseline persisted over eight years.  The exceptions to this pattern were observed 
on Trails B (executive functioning domain; β (Slope) = -0.581, p = 0.78; β (Intercept) = -13.877, 
p = 0.22) and the Word List Recognition task (memory domain; β (Slope) = -0.025, p = 0.49; β 
(Intercept) = 0.265, p = 0.23).  For both of these tasks, moderate alcohol use did not have a 
significant effect on either baseline functioning or rate of change over time.  For all slope-
intercept models, control variables include number of years of education, medical burden, and 
marital status.  Fit indices for all models can be found in Table 2. 
Prior to running the any of the structural equation models, a principal component analysis 
was conducted to ensure appropriate fit of the cognitive measures within each domain.  This was 
necessary to confirm that the each measure was accurately placed within the appropriate 
cognitive domain.  PCA serves to identify a set of dimensions that helps to explain the variance 
in a set of variables as well as to reduce a large set of correlated variables to fewer underlying 
orthogonal dimensions (Harlow, 2005).  The factor loadings, as well as the eigenvalues, of the 
PCA are provided in Table 3, all of which indicate a strong fit within their respective cognitive 
domains.   
Following this, the structural equation models were run to further examine the effect of 
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alcohol use on cognitive performance as mediated by CRP (H1, H2, H3).  The subsample of 
ADAMS participants included in these structural equation models consisted of the 250 
participants who had both CRP and ApoE data.  As displayed in Table 4, the sample was 
predominantly female (53.2%), largely White/ Caucasian (79.2%), and had a mean age of 82.47 
years (SD=5.45), and a mean education of 11.11 years (SD=4.14).  The sample reported a mean 
medical burden score of 6.33 (SD=3.73).  In addition, the mean CRP level was 2.77µg/mL 
(SD=2.34).  Approximately 71% of participants included in this study reported being abstinent 
from alcohol.  Table 4 provides separate sample characteristics for non-drinkers (n=178) and 
moderate drinkers (n=69).   
As expected, moderate drinkers differed significantly on certain variables compared to 
non-drinkers.  Specifically, compared to non-drinkers, moderate drinkers were more likely to be 
Caucasian (χ2(1, N=247)=6.85, p<0.01) , male (χ2(1, N=247)=13.40, p<0.001), and partnered (χ2(1, 
N=159)=4.75, p<0.05) .   
Results of a structural model (Figure 3) examining hypotheses H1, H2, and H3 with 
regard to the fluency domain suggest that the hypothesized model fit the data well 
(RMSEA=0.032; Comparative Fit Index (CFI)=0.976; χ2(df=26)=32.38, p=0.810).  Although the 
model demonstrated adequate fit, not all of the pathways in the model were statistically 
significant.   Contrary to the hypothesized model, moderate drinking was associated with neither 
lower levels of CRP (β=-0.275, SE=0.313, p=0.380) nor better performance on the measures of 
fluency (β=0.035, SE=0.681, p=0.959).  Also contrary to the hypothesized model, higher CRP 
values were significantly associated with better performance on the measures of fluency 
(β=0.267, SE=0.128, p=0.037).  The indirect pathway from alcohol to performance within the 
fluency domain through CRP was not statistically significant (β=-0.008, SE=0.011, p=0.456).  In 
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addition, ApoE was neither a significant predictor of CRP values (β=-0.351, SE=0.331, p=0.289) 
nor a significant moderator (β=-0.392, SE=0.683, p=0.566) of the relationship between alcohol 
use and CRP. 
Results for the second of these models examining the executive function domain suggest 
that the hypothesized model demonstrated a mediocre fit of the data (RMSEA=0.066; 
Comparative Fit Index (CFI)=0.856; χ2(df=23)=47.97, p<0.01).  Although the model demonstrated 
mediocre fit, the pathways in the model were not statistically significant.   Moderate drinking 
was associated with neither lower levels of CRP (β=-0.275, SE=0.313, p=0.380) nor better 
performance on the latent variable measuring executive functioning (β=1.609, SE=1.749, 
p=0.357).  Higher CRP values were also not associated with better performance in this cognitive 
domain (β=0.177, SE=0.355, p=0.617).  Further, the indirect pathway from alcohol to 
performance within the executive function domain through CRP was not statistically significant 
(β=-0.002, SE=0.006, p=0.753).  In addition, ApoE was neither a significant predictor of CRP 
values (β=-0.351, SE=0.331, p=0.289) nor a significant moderator (β=0.392, SE=0.683, p=0.566) 
of the relationship between alcohol use and CRP. 
Results for the third model relating to the visuospatial domain suggest that the 
hypothesized model fit the data well (RMSEA=0.060; Comparative Fit Index (CFI)=0.926; 
χ2(df=27)=50.870, p<0.01).  Although the model demonstrated adequate fit, the pathways in the 
model were not statistically significant. Moderate drinking was associated with neither lower 
levels of CRP (β=-0.275, SE=0.313, p=0.380) nor better performance in this cognitive domain 
(β=0.086, SE=0.323, p=0.790).  Higher CRP values were also not associated with better 
performance on the cognitive measures (β=0.089, SE=0.057, p=0.117).  Further, the indirect 
pathway from alcohol to performance within the visuospatial domain through CRP was not 
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statistically significant (β=-0.006, SE=0.009, p=0.523).  In addition, ApoE was neither a 
significant predictor of CRP values (β=-0.351, SE=0.331, p=0.289) nor a significant moderator 
(β=0.392, SE=0.683, p=0.566) of the relationship between alcohol use and CRP. 
Results for the fourth and penultimate model relating to the memory domain suggest that 
the hypothesized model demonstrated a mediocre fit of the data (RMSEA=0.067; Comparative 
Fit Index (CFI)=0.892; χ2(df=31)=65.513, p<0.001).  Although the model demonstrated a mediocre 
fit, the pathways in the model were not statistically significant.  Moderate drinking was neither 
associated with lower levels of CRP (β=-0.275, SE=0.313, p=0.380) nor better performance on 
the cognitive measures within the memory domain (β=0.096, SE=1.261, p=0.939).  Higher CRP 
values were not associated with better performance on the cognitive measures (β=0.245, 
SE=0.177, p=0.165).  Further, the indirect pathway from alcohol to performance within the 
memory domain through CRP was not statistically significant (β=-0.005, SE=0.008, p=0.539).  
In addition, ApoE was neither a significant predictor of CRP values (β=-0.351, SE=0.331, 
p=0.289) nor a significant moderator (β=0.392, SE=0.683, p=0.566) of the relationship between 
alcohol use and CRP. 
Results for last of these models examining global cognition suggests that the 
hypothesized model fit the data adequately (RMSEA=0.084; Comparative Fit Index 
(CFI)=0.848; χ2(df=162)=343.127, p<0.001).  Although the model demonstrated mediocre fit, the 
pathways within the model were not statistically significant.  Moderate drinking was neither 
associated with lower levels of CRP (β=-0.367, SE=0.37, p=0.323) nor better performance on the 
cognitive measures within the global domain (β=0.976, SE=1.592, p=0.540).  Higher CRP values 
were not associated with better performance on the cognitive measures (β=0.375, SE=0.301, 
p=0.214).  Further, the indirect pathway from alcohol to performance within the global domain 
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through CRP was not statistically significant (β=-0.138, SE=0.203, p=0.497).  In addition, ApoE 
was neither a significant predictor of CRP values (β=-0.337, SE=0.413, p=0.415) nor a 
significant moderator (β=0.308, SE=0.777, p=0.692) of the relationship between alcohol use and 
CRP. 
Dementia Diagnosis. 
The logistic regression and survival analysis (H5 & H6), were completed using the initial 
ADAMS sample consisting of 856 participants (demographics for the sample are displayed in 
Table 1).  Tables 5 and 6 provide separate sample characteristics for those in which a dementia 
onset occurred (n=407) and did not occur (n=449) as well as non-drinkers (n=679) and moderate 
drinkers (n=139).  As expected, certain variables differed significantly between those who 
received a dementia diagnosis and those who did not receive a diagnosis of dementia.   
Results of the logistic regression predicting dementia diagnosis are displayed in Table.7.  
Predictors that were used in the analysis include gender, age, education, race, and alcohol use 
(abstained or moderate use).  The overall model was significant (χ2[5]=172.80, p<0.001; and 
explained 25.4% (Nagelkerke R2) of the variance and classified 69.7% of cases correctly.  
Significant correlates of dementia diagnosis included gender (β=-0.50, Wald=9.39, p=0.002, 
Exp(β)=1.65), age (β=0.12, Wald=92.66, p<0.001, Exp(β)=1.13), education (β=-0.06, 
Wald=9.28, p=0.002, Exp(β)=0.94), and moderate alcohol use (β=-0.68, Wald=8.61, p=0.003, 
Exp(β)=0.51).  Race was not a significant predictor of dementia diagnosis (β=0.18, Wald=0.80, 
p=0.373, Exp(β)=1.19). 
Following this, a Kaplan-Meier survival analysis was performed to assess the effects of 
alcohol use (moderate versus abstaining) on the age of onset of dementia.  The Log Rank test 
indicates that there is a significant difference in the survival rate between the two groups 
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(χ2[1]=23.17, p<0.001).  Further, the median survival time for moderate users (β = 97.00, 
SE=3.378, 95% CI 90.38 – 103.62) was about eight years longer than those who abstained from 
alcohol use users (β = 89.00, SE=0.545, 95% CI 87.931 – 90.069).  Results of the survival 
analysis are presented in Figure 4. 
Following the logistic regression and survival analysis, a structural equation model was 
run to examine the hypothesis (H6, H7, H8) evaluating the effect of alcohol use on dementia 
diagnosis as mediated by CRP.  As with prior analyses incorporating CRP, this analysis included 
the subsample of 250 participants used to test H1-H3, above.  Demographics for these 
participants can be found in Table 4.  Results for this analysis suggest that the hypothesized 
model demonstrated a mediocre fit of the data (RMSEA=0.036; Comparative Fit Index 
(CFI)=0.882; χ2(df=9)=10.849, p=0.286).  Although the model demonstrated a mediocre fit, the 
pathways in the model were not statistically significant.  Moderate drinking was neither 
associated with lower levels of CRP (β=-0.296, SE=0.410, p=0.471) nor dementia diagnosis 
(β=0.251, SE=0.285, p=0.378).  Higher CRP values were not associated with increased risk of 
dementia diagnosis (β=-0.073, SE=0.057, p=0.203).  Further, the indirect pathway from alcohol 
to dementia diagnosis through CRP was not statistically significant (β=-0.022, SE=0.033, 
p=0.517).  In addition, ApoE was neither a significant predictor of CRP values (β=-0.371, 
SE=0.436, p=0.396) nor a significant moderator (β=0.264, SE=0.985, p=0.789) of the 
relationship between alcohol use and CRP. 
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CHAPTER SEVEN: DISCUSSION 
Cognitive Domains.  
Primary findings from this study partially support initial hypotheses.  Moderate alcohol use 
was broadly associated with better performance across cognitive measures at baseline, and these 
differences persisted over time with no significant differences in the rate of change in cognition. 
As hypothesized, number of years of education, medical burden, and marital status significantly 
predicted cognitive performance. More complex hypotheses, including CRP as a moderated 
mediator of the relationship between moderate drinking and cognitive functioning, however, 
were not supported.   
Overall, results of the slope-intercept models produced a similar pattern across cognitive 
domains.  In general, the slope-intercept models indicated that moderate alcohol use was 
significantly associated with better baseline performance, but did not have a significant effect on 
the rate of change over time in performance.  Although moderate use did not have a significant 
effect on rate of change over time, the baseline effect of better performance associated with 
moderate use persisted throughout the observed period time.  This indicates that there is a 
difference between the groups in cognitive performance over time.  Further, it is likely that the 
divergence of cognitive functioning between these groups takes place at an earlier age than that 
captured by the available data. 
The current findings support existing literature regarding the relationship between 
moderate alcohol use and cognitive functioning.  More specifically, this study supports the 
association between moderate alcohol use and better cognitive functioning (Albert, 2003; Imhof 
et al., 2001; Lang et al., 2007).  The current study also offers auxiliary evidence that expands 
upon the findings of past studies, particularly with regard to length of follow-up time and 
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comprehensiveness of the testing battery.  Specifically, although Stott et al. (2008) found an 
association between moderate alcohol consumption and decrease in cognitive decline, they had a 
limited follow-up period of 3.2 years.  Several previous studies utilized screening measures (i.e., 
MMSE, TICS) as assessments of cognitive functioning (Ganguli et al., 2005; Stampfer et al., 
2005; Stott et al., 2008). The current study employed a neuropsychological battery, which 
encompassed several different cognitive domains by use of psychometrically valid and reliable 
instruments.  With regard to classification of alcohol use, Ngandu et al. (2007) categorized those 
who drank less than once per month as ‘infrequent’ and those who drank more than once per 
month as ‘frequent’, which could cause ambiguity when interpreting results, particularly with  
respect to the amount that constitutes moderate drinking.  As the current study followed the 
NIAAA Guidelines for moderate drinking, this facilitates interpretation of findings within the 
context of the broader healthcare literature. 
Past research has also found that CRP typically circulates in low concentrations in healthy 
individuals (Stewart et al., 2002).  When investigating CRP levels among a sample of abstainers, 
moderate drinkers, and high frequency drinkers, Stewart, Mainous, and Gilbert (2002) found that 
nondrinkers had the highest percentage of individuals with elevated CRP levels (31%) when 
compared to 21% of low to moderate frequency drinkers, and 18% of high frequency drinkers; 
indicating that alcohol consumption is associated with a decreased CRP levels.  Further, Volpato 
et al. (2004) found that older adults who drank between 1 and 7 drinks had the lowest levels of 
CRP when compared with other participants who either abstained or consumed more than 7 
drinks on a weekly basis.   
The results of this study also contradict past findings, particularly those related to CRP 
and cognition.   Many studies have documented the link between lower CRP values and better 
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cognitive performance.  However, when examining the fluency domain, this study found the 
opposite; that higher CRP values were associated with improved cognitive performance.  More 
recent work examining the role of CRP in the very old (75 years and older) has examined the 
premise that elevated CRP levels, within this age group, may act as a protective factor 
surrounding cognitive decline.  Lima and colleagues (2014) utilized a longitudinal sample of the 
Medical Research Council Cognitive Function and Ageing Study (CFAS) to investigate the 
relationship between CRP and cognitive performance over a 4-year period (266 participants, 
mean age 77 years).  They found that increased levels of CRP were associated with a decreased 
risk of decline in cognitive performance; however, this relationship was only seen in those 
without an ApoE-4 allele.  Further, Silverman et al. (2009) found that among a cognitively 
healthy sample of older adults, aged 75 years or older (mean age 85 years), elevated CRP values 
were positively associated with better performance on memory measures, for those without an 
ApoE-4 allele.  However, Silverman and colleagues (2009) also found that elevated CRP values 
were modestly associated with comparably worse performance on measures of executive 
functioning.  As the sample in the current study included older adults between the ages of 73.83 
and 99.67 years of age, with a mean age of 82.47, it is possible that age played a factor in the 
relationship between CRP values and cognitive performance.  Conflicting results of past studies 
regarding CRP and cognition suggest a complex relationship, and it is possible that the results of 
the current study may serve as an additional piece of evidence that higher CRP values within the 
older-old age group serve as a buffer with regard to cognitive abilities in later life.  Future 
research may aim to further investigate the relationship between elevated CRP levels and 
cognitive functioning among individuals within the very old age group. 
The findings of this portion of the current study extend our knowledge of the relationship 
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between alcohol use and cognitive performance in later life.  As the population of older adults 
continues to grow, alcohol use among the elder population will likely increase in prevalence as 
well.  Findings from this study may also serve to build upon existing empirical literature and 
provide additional support for a protective factor with regard to cognitive aging.  In addition, 
results may also be utilized to provide supplementary empirically supported data with regard to 
the drinking guidelines for moderate use among older adults.  However, based on the current 
state of the literature, it would be premature to correlate the findings of this study with an 
increased benefit for cognitive rehabilitation and/or maintenance. 
Dementia Diagnosis.  
The primary conclusion, when examining the effect of moderate alcohol use on dementia 
diagnosis, is that moderate users of alcohol develop dementia at lower rates, and later in life, 
than do abstinent older adults. This finding supported a priori hypotheses.  The final logistic 
regression model, with control variables, explained 25.4% of the variance and classified 69.7% 
of cases correctly.  Results that dementia risk was also significantly predicted by gender, age, 
education, and race are consistent with past findings (Huang et al., 2002; Hulse et al., 2005).  In 
this sample, the median survival time for those who reported using alcohol moderately was about 
eight years longer than those who reported abstaining from alcohol use.  As with analyses 
predicting cognitive domain performance, hypotheses identifying CRP as a moderated mediator 
of the relationship between moderate drinking and dementia risk were not supported.  This 
model may have been more sensitive to the complex hypothesized effects had the subsample 
used for this portion of the analysis been larger.  Other possible causes of poor fit include 
variable relationships between CRP and other variables throughout later life, mentioned above 
(Lima et al., 2014; Silverman et al., 2009). 
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Conclusions 
Taken together, results suggest that older adults who consume alcohol in moderate levels 
(1-14 drinks/week) have better global cognition than those who abstain from use, which also 
translates to lower dementia risk with later dementia onset.  However, results do not support a 
mediating role of CRP in the relationship between moderate alcohol use and cognitive outcomes. 
The current findings build upon previous literature that has linked moderate alcohol with positive 
health outcomes in older age, including better cognitive performance and decreased risk of 
dementia (Albert, 2003; Huang et al., 2002; Hulse et al., 2005; Imhof et al., 2001; Lang et al., 
2007; Marmot & Brunner, 1991).   The current study builds on these findings by utilizing a 
larger, more representative sample, with a longer follow-up time, which may provide additional 
insight as to the timing of the benefits associated with moderate use and positive health 
outcomes. 
Directions for Future Research 
The current study hypothesized CRP as a potential biological mechanism by which the 
relationship between moderate alcohol use and cognitive functioning operates.  However, results 
did not support for this hypothesis.  Therefore, future research may aim to investigate additional 
biological mechanisms that could elucidate the relationship between moderate alcohol use and 
cognitive functioning in later life.  As moderate alcohol consumption typically involves a social 
component, one potential moderating variable of interest may involve the level of social 
interaction experienced by older adults.  Additionally, future research may also assess the 
likelihood by which moderate drinkers tend to also moderate additional lifestyle behaviors (i.e., 
diet, exercise, drug use, etc.) and the effect that this may have on subsequent cognitive 
performance.  Future research may also look to further examine the relationship between 
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elevated CRP levels and cognitive functioning among individuals within the very old age group, 
as this appears to be a complex relationship that may be mediated by age. 
In addition, as the current study found that moderate alcohol use was significantly 
associated with better baseline performance on cognitive measures, future studies may aim to 
investigate the effects of a change in pattern of consumption in later life (i.e., moderate consumer 
in midlife to abstainer in late life).  Lastly, prospective studies may also examine a wider-ranging 
age group, in order to better assess the age at which the divergence of cognitive functioning 
between moderate users and abstainers may take place.  
One of the limitations of this study includes the use of subjective data rather than objective 
data.  While this method obtaining alcohol use data is subject to measurement error, it is standard 
in alcohol research as collecting objective measures of alcohol use, such as blood alcohol levels, 
can be difficult due to both time and cost considerations.  In addition, self-report was used in 
order to calculate medical burden scores, in that participants either confirmed or denied the 
presence of physical disease(s).  While there have been weaknesses associated with self-report 
measures, this is a common method in obtaining data among population-cased samples.  A 
second limitation of the current study is the limited size of the sample.  As a result, this also 
limited the statistical power that is needed for complex analyses, such as structural equation 
modeling.  Further, the use of a moderated mediator tends to also require a significant amount of 
statistical power, and may have been underpowered due to the sample size limitation. 
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APPENDIX A: TABLES 
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Table 1: Sample Characteristics for all ADAMS Participants. 
   
     
    Total 
Non-Drinkers (0 
Drinks/Wk) 
Moderate Drinkers (1-14 
Drinks/Wk) 
    (n=856) (n=679) (n=139) 
Variable M(SD) M(SD) M(SD) 
Age† 81.56(7.17) 82.03(7.12) 79.77(7.29) 
Education (yrs)*** 10.03(4.35) 9.53(4.30) 12.17(4.09) 
Medical Burden* 7.08(3.673) 7.31(3.81) 5.98(2.96) 
  
Percentage of Sample 
Gender*** 
   
 
Male 41.40 36.70 61.20 
 
Female 58.60 63.10 38.80 
Partnered*** 38.90 35.60 53.20 
Race*** 
   
 
Caucasian 76.90 74.20 89.90 
  Other 23.10 25.80 10.10 
*** p≤0.001 
* p≤0.05 
   † n = 834 
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Table 2: Fit Indices and Results for Slope-Intercept Models of moderate alcohol use on cognitive 
performance over time. 
           RMSEA CFI χ2 β (Slope) β (Intercept) 
Executive Function Domain 
     
 
Trails B 0.027 0.988 14.179 -0.581 -13.877 
 
Symbol Digit Modalities 0.036 0.993 18.576 -0.034 3.108** 
Fluency 
     
 
Animal Fluency 0.000 1.000 9.853 0.004 2.390*** 
 
COWA 0.049 0.984 28.213** -0.243 3.441*** 
 
Digit Span 0.021 0.997 14.515 -0.093 1.344*** 
Visuospatial 
     
 
BVRT 0.000 1.000 8.555 0.010 0.422* 
 
Constructional Praxis 0.018 0.997 13.107 -0.021 0.474** 
 
Delayed Constructional 
Praxis 0.000 1.000 7.267 -0.051 0.783* 
Memory 
     
 
WMS II 0.008 0.999 11.517 0.042 2.178** 
 
FOME 0.000 1.000 9.323 -0.027 2.418** 
 
Delayed Word List 0.000 1.000 7.292 -0.017 0.566* 
  Word List Recognition 0.000 1.000 7.852 -0.025 0.265 
*** p≤0.001 
     **p≤0.01 
     * p≤0.05 
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Table 3: Exploratory Factor Analysis for Cognitive Domains  
 
Variable   Factor Loading Eigenvalues 
Executive Function Domain 
 
1.639 
 
Trails B 0.751 
 
 
Symbol Digit Modalities 0.759 
 Fluency Domain 
 
1.003 
 
Animal Fluency 0.510 
 
 
COWA 0.776 
 
 
Digit Span 0.729 
 Visuospatial Domain 
 
1.074 
 
BVRT 0.672 
 
 
Constructional Praxis 0.866 
 
 
Delayed Constructional 
Praxis 0.655 
 Memory Domain 
 
7.083 
 
WMSII 0.810 
 
 
FOME 0.741 
 
 
Delayed Word List 0.677 
   Word List Recognition 0.745   
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Table 4: Sample Characteristics for Participants with CRP & ApoE Data 
 
    Total 
Non-Drinkers (0 
Drinks/Wk) 
Moderate Drinkers (1-14 
Drinks/Wk) 
    (n=250) (n=178) (n=69) 
Variable M(SD) M(SD) M(SD) 
Age 
 
82.47(5.45) 82.88(5.69) 81.59(4.64) 
Education (years)*** 11.11(4.14) 10.47(4.34) 12.65(3.09) 
Medical Burden† 6.33(3.73) 6.51(3.91) 6.02(3.36) 
CRP 
 
2.77(2.34) 2.80(2.40) 2.53(2.06) 
  
Percentage of Sample 
Gender*** 
   
 
Male 46.80 39.30 65.20 
 
Female 53.20 60.70 34.80 
Partnered* 50.30 44.50 63.30 
Race** 
   
 
Caucasian 79.20 74.70 89.90 
  Other 20.80 25.30 10.10 
*** p≤0.001 
   **p≤0.01 
   * p≤0.05 
   † n = 161 
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Table 5: Dementia Sample Characteristics for Logistic Regression and Survival Analyses by 
Onset 
         Total Onset Occurred No Onset 
    (n=856) (n=407) (n=449) 
Variable M(SD) M(SD) M(SD) 
Age*** 81.56(7.17) 84.54(7.04) 78.95(6.21) 
Education (years)*** 10.03(4.35) 9.32(4.44) 10.68(4.17) 
  
Percentage of Sample 
Gender*** 
   
 
Male 41.40 32.20 49.70 
 
Female 58.60 67.80 50.30 
Race** 
   
 
Caucasian 76.90 73.00 80.40 
 
Other 23.10 27.00 19.60 
Alcohol Use*** 
   
 
Abstained 83.00 90.40 76.40 
  Moderate Use 17.00 9.60 23.60 
*** p≤0.001 
   **p≤0.01 
   * p≤0.05 
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Table 6: Dementia Sample Characteristics for Logistic Regression and Survival Analyses by 
Alcohol Use 
 
    Total 
Non-Drinkers (0 
Drinks/Wk) 
Moderate Drinkers (1-14 
Drinks/Wk) 
    (n=856) (n=679) (n=139) 
Variable M(SD) M(SD) M(SD) 
Age*** 81.56(7.17) 82.03(7.12) 79.77(7.29) 
Education (years)*** 10.03(4.35) 9.53(4.30) 12.17(4.09) 
  
Percentage of Sample 
Gender*** 
   
 
Male 41.40 36.70 61.20 
 
Female 58.60 63.30 38.80 
Race*** 
   
 
Caucasian 76.90 74.20 89.90 
 
Other 23.10 25.80 10.10 
Dementia 
Diagnosis*** 
   
 
No Onset 52.50 48.70 73.40 
  Onset Occurred 47.50 51.30 26.60 
*** p≤0.001 
   **p≤0.01 
   * p≤0.05 
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Table 7: Results of Logistic Regression Predicting Dementia Onset (n=818) 
 
  β SE Wald Exp(β) 
Gender -0.50 0.16 9.39** 0.61 
Age 0.12 0.01 92.66*** 1.13 
Education 
(years) -0.06 0.02 9.28** 0.94 
Race 0.18 0.20 0.80 1.19 
Alcohol Use -0.68 0.23 8.61** 0.51 
*** p≤0.001 
    **p≤0.01 
    * p≤0.05 
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APPENDIX B: FIGURES 
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Figure 1:  Sample selection for participants with ApoE & CRP data. 
  
Participants with missing values on x variables were 
excluded in Mplus (i.e. 2 participants missing ApoE values) 
856 
(Total Number of 
ADAMS Participants) 
245 
(Final Sample) 
 
Excluded participants who had 
missing CRP data 
279 
Excluded participants who had 
CRP values or CRP values above 
10 00 / L 
Excluded participants who reported heavy 
drinking (i.e. >14 drinks/week) 
 
250 
 
247 
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Figure 2:  Slope-Intercept Model for Animal Fluency (AF).  
Medical Burden 
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Moderate 
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 52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3: Structural model depicting the relationship between moderate alcohol use, C-reactive 
protein, and the fluency domain.  
*p≤0.05; **p≤0.01; ***p≤0.001; CRP=C-reactive protein; ApoE=Apolipoprotein-E 
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Figure 4:  Survival Analysis for Dementia Onset according to Alcohol Use. 
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